Survival outcomes in patients with advanced non-small cell lung cancer treated with erlotinib: expanded access programme data from Belgium (the TRUST study)

2013 ◽  
Vol 23 (3) ◽  
pp. 370-379 ◽  
Author(s):  
J. Van Meerbeeck ◽  
D. Galdermans ◽  
F. Bustin ◽  
L. De Vos ◽  
I. Lechat ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Survival Outcomes ◽  
Small Cell Lung ◽  
Expanded Access ◽  
Expanded Access Programme ◽  
Access Programme

scholarly journals Erlotinib in salvage treatment of patients with advanced non-small cell lung cancer: results of an expanded access programme in Poland

2012 ◽  
Vol 2 ◽  
pp. 170-175
Author(s):  
Dariusz M. Kowalski ◽  
Maciej Krzakowski ◽  
Rodryg Ramlau ◽  
Piotr Jaskiewicz ◽  
Anna Janowicz-Żebrowska
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Salvage Treatment ◽  
Small Cell ◽  
Small Cell Lung ◽  
Expanded Access ◽  
Expanded Access Programme ◽  
Access Programme
Sign in / Sign up

Export Citation Format

Share Document